New Data Reveals Metformin’s Role in Early Pregnancy Success – Fertility Plus
Fertility Plus shared a post on LinkedIn:
“Don’t Stop Metformin at a Positive Test: New Data Shows Continuing Through Trimester 1 Cut Miscarriage Risk in Half
A massive new systematic review and meta-analysis published in the American Journal of Obstetrics and Gynaecology analysed data from over 1,700 women to settle the debate on metformin timing. The results showed that continuing metformin through the first trimester significantly boosted clinical pregnancy rates and reduced the odds of miscarriage by over 50% compared to stopping immediately upon confirmation. Researchers propose that abrupt stopping causes a harmful ‘insulin rebound’ effect during critical early fetal development.
A systematic review and meta-analysis of 12 Randomized Controlled Trials (n=1,708) published in the American Journal of Obstetrics and Gynecology.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Mar 23, 2026, 13:26Sergei Gorlovetsky: Why Up to 40% of IVF Patients Never Start Treatment?
-
Mar 23, 2026, 13:18Asma Khalil: Great to Be in Antwerp for the 6th International Conference on Maternal Hemodynamics
-
Mar 23, 2026, 13:08Christopher Robinson: Obstetric Anal Sphincter Injuries Assessed in 21-Year Nulliparous Birth Study
-
Mar 23, 2026, 12:20ENGOT Assembly Showcases Progress in Gynaecological Oncology – ENGOT
-
Mar 23, 2026, 12:12Endometriosis Awareness Month Explore Free Resources and Insights – ESHRE
-
Mar 23, 2026, 12:06Join the Fertility and Sterility Roundtable Podcast Opportunity – Fertility and Sterility
-
Mar 23, 2026, 11:54Upcoming ISUOG Fetal Cardiology Conference with Insights from Rabih Chaoui – ISUOG
-
Mar 23, 2026, 11:44PCOS Awareness Must Go Beyond Trying to Conceive – PCOS Awareness Association
-
Mar 23, 2026, 11:20Egg Donation and Freezing Under Review at WEC Inquiry – HFEA